The tariff classification of a prototype medical robotic system from Canada
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated August 27, 2025, you requested a tariff classification ruling on behalf of your client, Insight Medbotics. You state that Insight Medbotics has developed a prototype medical robotic system for product evaluation. This prototype is not approved for human use by the FDA and is exclusively for testing technical capabilities and gathering feedback from physicians and key opinion leaders.
These evaluations, conducted in non-clinical settings like offices or conference rooms in the United States, involve demonstrating the robot's capabilities on a resin anatomical model through mock procedures. During a mock procedure, the robot's manipulator is moved to different orientations, and off-the-shelf accessories are inserted into the resin model. This demonstration allows physicians to experience firsthand how the device might be used.
The feedback collected helps refine the design and development of the system. Additionally, the prototype undergoes technical evaluations in specialized U.S. labs to test parameters such as electromagnetic interference, bio-material compatibility, magnetic interference, and MRI image artifacts, as well as human factors evaluations using the prototype. All testing and evaluations with this prototype are performed on test models, not on humans.
The Insight Medbotics robotic system consists of several components and accessories needed to: 1) demonstrate the full capabilities of the system using different accessories - all medical accessories are labelled “For Demonstration Purposes Only”, 2) Perform repairs, and 3) Protect the system and accessories during shipment. The components and accessories always accompany the system and are shipped back to the country of origin (Canada), after the evaluation is completed.
The component list includes: 1 - Insight Medbotics Robotic Platform 1 - Insight Medbotics Control Box 1 - Insight Medbotics Spare Carriage 2 - Spare Stepper Motor 1 - Spare Motor Drive 1 - Digital Multimeter 1 - Precision Driver and Bit Set 1 - Longnose Pliars 1 - Philips Screwdriver 1 - HD26 D-Sub Cable 2.5ft 1 - HD26 D-Sub Cable 5ft 1 - Power Cord NEMA 1 - USB Cable A to B 6.5ft 1 - USB Cable A to B 16.5ft 1 - Phatom Prostate w/Lesion 1 - Medical needles BIM 18/20i 1 - Medical needles KIM 16/14T 1 - Medical needles BAM 18/20 1 - Apple AirTag 1 - Nanuk 996 Black Case 2 - Nanuk TSA Lock You inquired about whether the prototype medical robotic system qualifies for duty free treatment as a prototype under subheading 9817.85.01, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Prototypes to be used exclusively for development, testing, product evaluation, or quality control purposes.” Based on the information presented, we find that the prototype medical robotic system qualifies for duty free treatment as a prototype under subheading 9817.85.01, provided that all of the conditions delineated in U.S. Note 7, Chapter 98, Subchapter XVII, Harmonized Tariff Schedule of the United States, (HTSUS) are satisfied.
The tariffs and additional duties cited above are current as of this ruling’s issuance. Duty rates are provided for your convenience and are subject to change.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N352983).